β-Catenin is a positive regulator of estrogen receptor- α function in breast cancer cells

Cancers

Volumn 3, Issue 3, 2011, Pages 2990-3001

  Gupta, Nibedita ^a   Schmitt, Fee ^a   Grebhardt, Sina ^a   Mayer, Doris ^a  

^a GERMAN CANCER RESEARCH CENTER   (Germany)

Author keywords

catenin; Breast cancer cells; Cross talk; Estrogen receptor; Gene expression; Transcriptional activity

Indexed keywords

BETA CATENIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL LYSATE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GREB1 GENE; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; ONCOGENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PS2 GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 80053208657     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3032990     Document Type: Article

References (24)

1. Tzukerman, M.T.; Esty, A.; Santiso-Mere, D.; Danielian, P.; Parker, M.G.; Stein, R.B.; Pike, J.W.; McDonnell, D.P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 1994, 8, 21-30.
2. Hewitt, S.C.; Korach, K.S. Estrogen receptors: structure, mechanisms and function. Rev. Endocr. Metab. Disord. 2002, 3, 193-200.
3. McDevitt, M.A.; Glidewell-Kenney, C.; Jimenez, M.A.; Ahearn, P.C.; Weiss, J.; Jameson, J.L.; Levine, J.E. New insights into the classical and non-classical actions of estrogen: Evidence from estrogen receptor knock-out and knock-in mice. Mol. Cell. Endocrinol. 2008, 290, 24-30.
4. Lannigan, D. Estrogen receptor phosphorylation. Steroids 2003, 68, 1-9.
5. Likhite, V.S.; Stossi, F.; Kim, K.; Katzenellenbogen, B.S.; Katzenellenbogen, J.A. Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity. Mol. Endocrinol. 2006, 20, 3120-3132.
6. Grisouard, J.; Mayer, D. Specific involvement of glycogen synthase kinase-3 in the function and activity of sex steroid hormone receptors reveals the complexity of their regulation. J. Steroid Biochem. Mol. Biol. 2009, 117, 87-92.
7. Murphy, L.C.; Seekallu, S.V.; Watson, P.H. Clinical significance of estrogen receptor phosphorylation. Endocr. Relat. Cancer 2011, 18, R1-R14.
8. Medunjanin, S.; Hermani, A.; De Servi, B.; Grisouard, J.; Rincke, G.; Mayer, D. Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor-_ and is involved in the regulation of receptor activity. J. Biol. Chem. 2005, 280, 33006-33014.
9. Grisouard, J.; Medunjanin, S.; Hermani, A.; Shukla, A.; Mayer, D. Glycogen synthase kinase-3 protects estrogen receptor-_ from proteasomal degradation and is required for full transcriptional activity of the receptor. Mol. Endocrinol. 2007, 21, 2427-2439.
10. Cardona-Gomez, P.; Perez, M.; Avila, J.; Garcia-Segura, L.M.; Wandosell, F. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol. Cell. Neurosci. 2004, 25, 363-373.
11. Kouzmenko, A.P.; Takeyama, K.; Ito, S.; Furutani, T.; Sawatsubashi, S.; Maki, A.; Suzuki, E.; Kawasaki, Y.; Akiyama, T.; Tabata, T.; Kato, S. Wnt/beta-catenin and estrogen signaling converge in vivo. J. Biol. Chem. 2004, 279, 40255-40258.
12. Truica, C.I.; Byers, S.; Gelmann, E.P. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res. 2000, 60, 4709-4713.
13. Mulholland, D.J.; Dedhar, S.; Coetzee, G.A.; Nelson, C.C. Interaction of nuclear receptors with the Wnt/_-catenin/Tcf signaling axis: Wnt you like to know? Endocr. Rev. 2005, 26, 898-915.
14. Prosperi, J.R.; Goss, K.H. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer. Curr. Drug Targets 2010, 11, 1074-1088.
15. Saceda, M.; Lippman, M.E.; Chambon, P.; Lindsey, R.L.; Ponglikitmongkol, M.; Puente, M.; Martin, M.B. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol. Endocrinol. 1988, 2, 1157-1162.
16. Laïos, I.; Journé, F.; Nonclercq, D.; Vidal, D.S.; Toillon, R.A.; Laurent, G.; Leclerq, G. Role of the proteasome in the regulation of estrogen receptor alpha turnover and function in MCF-7 breast carcinoma cells. J. Steroid Biochem. Mol. Biol. 2005, 94, 347-359.
17. Klinge, C.M. Estrogen receptor interaction with estrogen response elements. Nucleic Acid Res. 2001, 29, 2905-2919.
18. Deschênes, J.; Bourdeau, V.; White, J.H.; Mader, S. Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences. J. Biol. Chem. 2007, 282, 17335-17339.
19. Shukla, A.; Grisouard, J.; Ehemann, V.; Hermani, A.; Enzmann, H.; Mayer, D. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines. Endocr. Relat. Cancer 2009, 16, 429-441.
20. Hatsell, S.; Rowlands, T.; Hiremath, M.; Cowin, P. βCatenin and Tcfs in mammary gland development and cancer. J. Mamm. Gland Biol. Neoplasia 2003, 8, 145-158.
21. Shtutman, M.; Zhurinsky, J.; Simcha, I.; Albanese, C.; D'Amico, M.; Pestell, R.; Ben-Ze'ev, A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 1999, 96, 5522-5227.
22. Medunjanin, S.; Weinert, S.; Schmeisser, A.; Mayer, D.; Braun-Dullaeus, R.C. Interaction of the double-strand break repair kinase DNA-PK and estrogen receptor-alpha. Mol. Biol. Cell 2010, 21, 1620-1628.
23. Balaguer, P.; Francois, F.; Comunale, F.; Fenet, H.; Boussioux, A.M.; Pons, M.; Nicolas, J.C.; Casellas, C. Reporter cell lines to study the estrogenic effects of xenoestrogens. Sci. Total. Environ. 1999, 233, 47-56.
24. Migliaccio, A.; Pagano, M.; Auricchio, F. Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene 1993, 8, 2183-2191.